Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

by Business Wire • 2025/12/16 • 0 Comments

LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Henric Bjarke, Chief Executive Officer is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 10 a.m. PST/ 1 p.m. EST. The Company’s lead investigational asset, BRIMOCHOL™ PF, is designed to be the first and only combinatio

← Secukinumab Fails to Show Benefit in Graves’ Orbitopathy

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction →

Post navigation